Table 1.
E1594: Patient Characteristics According to Histology
| Histology |
All Patients n = 1,139 |
||||
|---|---|---|---|---|---|
| Characteristics | Squamous Cell Carcinoma n = 224 |
Adenocarcinoma n = 647 |
Large Cell Carcinoma n = 74 |
Others/Not Otherwise Specified n = 194 |
|
| Age (year) | |||||
| Median | 63 | 61 | 63 | 61 | 61 |
| Range | 39-79 | 25-86 | 44-78 | 32-83 | 25-86 |
|
| |||||
| Sex (%) | |||||
| Male | 72.8 | 59.0 | 68.9 | 61.9 | 62.9 |
| Female | 27.2 | 41.0 | 31.1 | 38.1 | 37.1 |
|
| |||||
| Race (%) | |||||
| White | 86.5 | 85.6 | 89.2 | 84.0 | 85.7 |
| Black | 10.4 | 9.4 | 5.4 | 9.3 | 9.3 |
| Other | 3.1 | 5.0 | 5.4 | 6.7 | 4.9 |
|
| |||||
| Performance Status (%) | |||||
| 0 | 31.7 | 30.9 | 28.4 | 29.4 | 30.6 |
| 1 | 60.7 | 64.0 | 66.2 | 66.0 | 63.8 |
| 2 | 7.6 | 5.1 | 5.4 | 4.6 | 5.5 |
|
| |||||
| Brain metastases (%) | 10.7 | 13.6 | 14.9 | 8.2 | 12.2 |
|
| |||||
| Weight loss >5% (%) | 35.3 | 31.4 | 40.5 | 34.0 | 33.2 |
|
| |||||
| Disease Stage (%) | |||||
| IIIB | 12.1 | 15.6 | 10.8 | 7.7 | 13.3 |
| IV/Recurrent | 87.9 | 84.4 | 89.2 | 92.3 | 86.7 |
|
| |||||
| Treatment Regimens (%) | |||||
| Cisplatin-Paclitaxel | 26.8 | 26.3 | 17.6 | 22.7 | 25.2 |
| Cisplatin-Gemcitabine | 22.3 | 25.5 | 23.0 | 24.7 | 24.6 |
| Cisplatin-Docetaxel | 25.0 | 22.9 | 39.2 | 27.3 | 25.1 |
| Carboplatin-Paclitaxel | 25.9 | 25.3 | 20.3 | 25.3 | 25.1 |